About this trial
This study is aimed at clarifying changes in body composition during the perioperative period and identifying risk factors for skeletal muscle mass loss in patients with colorectal cancer. The investigators will asess the impact of the type of anaesthesia (total intravenous anaesthesia/sevoflurane anaesthesia) for colorectal surgery on the muscle function and mass, which will be evaluated using ultrasound, dynamometry and bioimpedance.
Eligibility criteria
Qualifiers
None
Disqualifiers
lack the capacity to consent
extremity amputation
paraplegia
diseases affecting the muscles (such as stroke, lower-limb immobilization from a plaster, neurodegenerative diseases, peripheral neuropathy or muscle dystrophy)
Trial design
Treatments tested in this trial
- total intravenous anaesthesia
- sevoflurane anaesthesia
Treatment groups
Sponsors and collaborators
Grigore T. Popa University of Medicine and Pharmacy
Lead sponsor
Regional Institute of Oncology, Iasi, Romania
Collaborator